Effect of Prophylactic Administration of Oxytocin in Uniject™ on Postpartum Hemorrhage at Home Births in Ghana
- Conditions
- Postpartum Hemorrhage
- Interventions
- Other: Oxytocin in Uniject
- Registration Number
- NCT01108289
- Lead Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Brief Summary
This study is designed to test the hypothesis that the intramuscular administration of 10 IU of oxytocin in Uniject™ during the third stage of labor by a Community Health Officer (CHO) at home births in Ghana will reduce the risk of postpartum hemorrhage by 50 percent relative to home births attended by the same type of provider who does not provide a uterotonic drug.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 1586
- home delivery
- presence of Community Health Officer at time of delivery
- None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Oxytocin in Uniject Oxytocin in Uniject Community Health Officers will provide 10 IU Oxytocin in Uniject device IM immediately after delivery of baby
- Primary Outcome Measures
Name Time Method postpartum hemorrhage-1 after delivery of baby blood loss \>=500 ml after delivery of the baby, as measured through plastic calibrated drape
postpartum hemorrhage-2 after delivery of the baby blood loss \>=500ml OR treatment dose of oxytocin provided
postpartum hemorrhage-3 after delivery of the baby blood loss \>=500ml OR treatment dose of oxytocin provided OR referral for bleeding
- Secondary Outcome Measures
Name Time Method Oxytocin use before delivery labor and delivery the proportion of deliveries where oxytocin in uniject was administered prior to the delivery of the baby
stillbirth labor/delivery stillbirth is defined as death of a fetus after 28 weeks of gestation, prior to birth
neonatal death first month of life neonatal death is defined as death of a live born baby prior to completion of 28 days
need for neonatal resuscitation 0-6 hours after birth
Trial Locations
- Locations (1)
Kintampo Health Research Center
🇬🇭Kintampo, Brong Ahafo, Ghana